Proposed clinical lab fee schedule: Take a look at proposed drug screen changes now to gauge coding, pay impacts

Why This Topic Matters

Drug screen reimbursement and reporting requirements can affect laboratory revenue, payer behavior, and claim submission workflows. Understanding proposed CMS changes early helps organizations assess operational and financial impact before final code adoption.

Article Sections

1. Overview of proposed CMS drug screen changes

   Introduces the CMS proposal for 2016 and explains why laboratories and practices should review the changes in advance. The section frames the potential implications for coding and reimbursement.

2. Revised presumptive testing code framework

   Describes the proposed presumptive testing code structure and how it differs from earlier expectations. It also notes common features across the proposed presumptive codes and the general basis for code selection.

3. Proposed presumptive placeholder codes and estimated payments

   Lists the placeholder presumptive code set and discusses the associated estimated payment amounts. The section also highlights a proposed descriptor change and an inquiry for clarification.

4. Proposed definitive testing code framework

   Summarizes the proposed definitive testing code structure and its relationship to laboratory testing categories. It explains that reporting is organized around the number of drug classes tested and includes the placeholder definitive codes.

5. Additional CMS follow-up and resources

   Notes that further changes may occur before finalization and points readers to related CMS resource materials. The section closes with references to the source documents cited in the article.